Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial
在美国，一项针对轻度至中度血管性血友病（VWDMin）患者，采用重组血管性血友病因子和氨甲环酸治疗月经过多的3期开放标签随机交叉试验
期刊:Lancet Haematology
影响因子:17.7
doi:10.1016/S2352-3026(23)00119-9
Ragni, Margaret V; Rothenberger, Scott D; Feldman, Robert; Nance, Danielle; Leavitt, Andrew D; Malec, Lynn; Kulkarni, Roshni; Sidonio, Robert Jr; Kraut, Eric; Lasky, Joseph; Pruthi, Rajiv; Angelini, Dana; Philipp, Claire; Hwang, Nina; Wheeler, Allison P; Seaman, Craig; Machin, Nicoletta; Xavier, Frederico; Meyer, Michael; Bellissimo, Daniel; Humphreys, Gregory; Smith, Kenneth J; Merricks, Elizabeth P; Nichols, Timothy C; Ivanco, Dana; Vehec, Deborah; Koerbel, Glory; Althouse, Andrew D
